Qiongqiong Angela Zhou

Qiongqiong Angela Zhou has a diverse work experience that spans various industries and roles. Qiongqiong Angela started their career at the University of Southern California as a Research Associate, where they established a proteomic comparison system and conducted brain dissection and primary neuron culture. Qiongqiong Angela then moved on to Johns Hopkins University as a Postdoc Fellow, where they made significant contributions in imaging, cell viability, and mutagenesis research, including identifying tumorigenesis factors and validating genes as compound targets. At Boston Children's Hospital, Qiongqiong worked as a Lab Supervisor, overseeing laboratory operations. Qiongqiong Angela continued their academic career as an Assistant Professor at Missouri State University, teaching and conducting research in the field of biology. Qiongqiong Angela later became a Visiting Assistant Professor at Denison University, where they further honed their teaching skills. Qiongqiong joined CAS as an Information Scientist and subsequently took on roles as a Scientific Content Creation and Development Supervisor and currently as a Manager, Scientific Analysis and Insights. Qiongqiong Angela'sresponsibilities in these positions involve scientific analysis, content creation, and supervising teams. Throughout their career, Qiongqiong has published peer-reviewed articles, contributed to scientific reviews, and successfully applied for grants from prestigious organizations such as NIH, American Cancer Society, and American Heart Association.

Qiongqiong Angela Zhou completed their education in a chronological order as follows:

From 1998 to 2002, they attended Fudan University and obtained a Bachelor's degree in Biology.

Subsequently, from 2002 to 2006, they pursued a Doctor of Philosophy (PhD) in Molecular Pharmacology and Toxicology at the University of Southern California.

Starting in 2006 and concluding in 2009, Qiongqiong Angela Zhou attended The Johns Hopkins University School of Medicine, where they obtained a Postgraduate Degree in Cell Biology.

Following this, from 2009 to 2011, they enrolled at Harvard Medical School and completed a Postgraduate Degree in Cancer Biology.

Additionally, it is mentioned that they pursued a Doctor of Philosophy (PhD) in Pharmacology and Toxicology at the University of Southern California, although specific dates for this degree are unavailable.